Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
26.69
-1.24 (-4.44%)
At close: Jun 12, 2025, 4:00 PM
26.69
0.00 (0.00%)
Pre-market: Jun 13, 2025, 4:03 AM EDT
Veracyte Market Cap
Veracyte has a market cap or net worth of $2.09 billion as of June 13, 2025. Its market cap has increased by 31.45% in one year.
Market Cap
2.09B
Enterprise Value
1.85B
1-Year Change
31.45%
Ranking
Category
Stock Price
$26.69
Market Cap Chart
Since October 30, 2013, Veracyte's market cap has increased from $274.10M to $2.09B, an increase of 662.57%. That is a compound annual growth rate of 19.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2025 | 2.19B | -28.73% |
| Dec 31, 2024 | 3.07B | 52.74% |
| Dec 29, 2023 | 2.01B | 18.01% |
| Dec 30, 2022 | 1.70B | -41.83% |
| Dec 31, 2021 | 2.93B | 3.30% |
| Dec 31, 2020 | 2.83B | 107.80% |
| Dec 31, 2019 | 1.36B | 167.37% |
| Dec 31, 2018 | 510.00M | 129.42% |
| Dec 29, 2017 | 222.30M | 2.77% |
| Dec 30, 2016 | 216.30M | 8.58% |
| Dec 31, 2015 | 199.20M | -8.37% |
| Dec 31, 2014 | 217.40M | -28.72% |
| Dec 31, 2013 | 305.00M | 11.27% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.64B |
| Johnson & Johnson | 376.43B |
| Novo Nordisk | 353.20B |
| AbbVie | 334.73B |
| UnitedHealth Group | 275.58B |
| Abbott Laboratories | 233.36B |
| Novartis AG | 232.35B |
| AstraZeneca | 227.75B |